ECM
AUPH icon

ExodusPoint Capital Management’s Aurinia Pharmaceuticals AUPH Stock Holding History

ExodusPoint Capital Management’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-72,462
Closed -$801K – 1539
2025
Q3 		$801K Sell
72,462
-57,723
-44% -$630K 0.01% 1039
2025
Q2 		$1.1M Buy
130,185
+73,685
+130% +$591K 0.01% 926
2025
Q1 		$454K Buy
56,500
+3,000
+6% +$24.3K ﹤0.01% 1127
2024
Q4 		$480K Buy
+53,500
New +$437K ﹤0.01% 1166
2023
Q4 		– Sell
-345,814
Closed -$2.69M – 1465
2023
Q3 		$2.69M Buy
345,814
+297,782
+620% +$2.91M 0.03% 580
2023
Q2 		$465K Buy
48,032
+8,354
+21% +$86.7K ﹤0.01% 1387
2023
Q1 		$435K Buy
39,678
+3,156
+9% +$27.8K ﹤0.01% 1372
2022
Q4 		$158K Buy
+36,522
New +$212K ﹤0.01% 1486
2022
Q3 		– Sell
-180,472
Closed -$1.81M – 1863
2022
Q2 		$1.81M Buy
180,472
+26,148
+17% +$292K 0.02% 820
2022
Q1 		$1.91M Buy
154,324
+6,525
+4% +$101K 0.02% 803
2021
Q4 		$3.38M Buy
+147,799
New +$3.5M 0.04% 564
2021
Q2 		– Sell
-11,336
Closed -$147K – 2328
2021
Q1 		$147K Buy
+11,336
New +$164K ﹤0.01% 1923
2020
Q4 		– Sell
-21,988
Closed -$324K – 1951
2020
Q3 		$324K Buy
+21,988
New +$319K 0.01% 1244
2019
Q4 		– Sell
-28,400
Closed -$152K – 1517
2019
Q3 		$152K Buy
+28,400
New +$172K 0.01% 1181

Other funds holding AUPH

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

ExodusPoint Capital Management's AUPH Position: Q4 2025 in Review

ExodusPoint Capital Management sold out of Aurinia Pharmaceuticals (AUPH) in Q4 2025, closing a stake of 72,462 shares — an estimated $801K sold.

ExodusPoint Capital Management first reported a position in AUPH in Q3 2019 and held it in 14 quarters. The position peaked at $3.38M in Q4 2021. 255 funds tracked by Wall St. Rank hold AUPH as of Q4 2025.

  • ExodusPoint Capital Management reported no remaining Aurinia Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • ExodusPoint Capital Management sold 72,462 Aurinia Pharmaceuticals shares in Q4 2025, an estimated $801K.
  • ExodusPoint Capital Management first reported a position in Aurinia Pharmaceuticals in Q3 2019 and held it in 14 quarters.
  • ExodusPoint Capital Management's Aurinia Pharmaceuticals position peaked at $3.38M in Q4 2021.
  • 255 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q4 2025.

Based on ExodusPoint Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.